AGP Executive Report
Last update: 3 hours agoGLP-1 Safety Watch: A new report raises alarm about whether combining GLP-1 weight-loss drugs with clozapine could worsen gut-slowing side effects, as both medicines can affect bowel movement. Wildfire Health: BC is handing back some wildfire protection resources as the Bald Range blaze shifts, but smoke risks remain a major public health concern. Air Quality Guidance: A mold and air-quality expert urges Canadians to check outdoor pollution daily and limit exposure indoors when levels spike, citing short- and long-term health impacts. Public Health Alerts: Toronto Public Health is investigating legionnaires’ disease outbreaks near the downtown core, adding to the week’s focus on respiratory and water-related risks. Medication Recall: Teva Canada is recalling pregabalin capsules over contamination concerns involving sertraline. Health System Security: Manitoba’s largest hospital is still recovering after a ransomware attack, highlighting ongoing cyber risk in care settings. Food Insecurity, With Choice: Hamilton’s new “food lifeline” model gives whānau a more flexible, points-based way to access groceries alongside support services. Clinical Research & Innovation: Ingenia Therapeutics has launched on KOSDAQ to accelerate vascular-targeted antibody therapies, including late-stage retina programs.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
